O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Próximos SlideShares
Childhood asthma.pptx
Childhood asthma.pptx
Carregando em…3
×

Confira estes a seguir

1 de 6 Anúncio

Asthma

Baixar para ler offline

The asthma have prevalence rate of 15-20 % in many countries.
U.S have 7.6% of prevalence rate.
Globally 339 million people are suffering from asthma.
Anti-inflammatories and Anticholinergics are taken as medication for patient suffering from asthma.
Teva Pharmaceutical Industries Ltd., Merck & Co., AstraZeneca Plc, GlaxoSmithKline Plc, Sanofi-Aventis SA, Philips Healthcare, Sunovion Pharmaceuticals, CareFusion Corporation, Inc., Boehringer Ingelheim GmbH and Roche are the leading players in asthma market.
Asthma is a chronic disease of the airways of the lungs.
The airways get narrow, swell and might produce extra mucus.
This results in breathing difficulties.
Cause:
Asthma occurs due environmental effects
Inherited (genetic) factors
History of viral infections
Hygiene hypothesis
Symptoms:
Shortness of breath
Anxiousness or panic
Chest tightness or pain
Coughing or wheezing attacks

Diagnosis:
No single test is design to test asthma. Doctor will ask about medical history of respiration infection and do physical examination.
Test to determine the lung conditions:
Spirometry
Peak flow
Doctor also ask to go for different test include:
Allergy testing
Sputum eosinophils
Methacholine challenge
Nitric oxide test or FeNO test
Imaging tests
Treatment:
Breathing exercises
Quick-acting treatments
Long-term asthma control medications
Long-term asthma control medications
Anti-inflammatories
Anticholinergics
Long-acting bronchodilators
Biologic therapy drugs
Medication are taken directly (oral) or by inhalation of corticosteroids (fluticasone (Flovent Diskus, Flovent HFA, Arnuity Ellipta), mometasone (Asmanex), budesonide (Pulmicort Flexhaler), ciclesonide (Alvesco), beclomethasone (Qvar), flunisolide (Aerobid) and others).

The asthma have prevalence rate of 15-20 % in many countries.
U.S have 7.6% of prevalence rate.
Globally 339 million people are suffering from asthma.
Anti-inflammatories and Anticholinergics are taken as medication for patient suffering from asthma.
Teva Pharmaceutical Industries Ltd., Merck & Co., AstraZeneca Plc, GlaxoSmithKline Plc, Sanofi-Aventis SA, Philips Healthcare, Sunovion Pharmaceuticals, CareFusion Corporation, Inc., Boehringer Ingelheim GmbH and Roche are the leading players in asthma market.
Asthma is a chronic disease of the airways of the lungs.
The airways get narrow, swell and might produce extra mucus.
This results in breathing difficulties.
Cause:
Asthma occurs due environmental effects
Inherited (genetic) factors
History of viral infections
Hygiene hypothesis
Symptoms:
Shortness of breath
Anxiousness or panic
Chest tightness or pain
Coughing or wheezing attacks

Diagnosis:
No single test is design to test asthma. Doctor will ask about medical history of respiration infection and do physical examination.
Test to determine the lung conditions:
Spirometry
Peak flow
Doctor also ask to go for different test include:
Allergy testing
Sputum eosinophils
Methacholine challenge
Nitric oxide test or FeNO test
Imaging tests
Treatment:
Breathing exercises
Quick-acting treatments
Long-term asthma control medications
Long-term asthma control medications
Anti-inflammatories
Anticholinergics
Long-acting bronchodilators
Biologic therapy drugs
Medication are taken directly (oral) or by inhalation of corticosteroids (fluticasone (Flovent Diskus, Flovent HFA, Arnuity Ellipta), mometasone (Asmanex), budesonide (Pulmicort Flexhaler), ciclesonide (Alvesco), beclomethasone (Qvar), flunisolide (Aerobid) and others).

Anúncio
Anúncio

Mais Conteúdo rRelacionado

Semelhante a Asthma (20)

Anúncio

Mais recentes (20)

Asthma

  1. 1. ASTHMA By Pranay Kumar :- pranayraju66@gmail.com
  2. 2. ❑ Asthma Overview ▪ Executive Summary ▪ Introduction ❑ Epidemiology – Asthma ▪ Global Asthma Epidemiology ▪ Asthma Prevalence Rate – U.S 2 TableOfContent
  3. 3. Executive Summary 3 Asthma -Overview Introduction ❑ Asthma is a chronic disease of the airways of the lungs. ❑ The airways get narrow, swell and might produce extra mucus. ❑ This results in breathing difficulties. ❑ Cause: ▪ Asthma occurs due environmental effects ▪ Inherited (genetic) factors ▪ History of viral infections ▪ Hygiene hypothesis ❑ Symptoms: ▪ Shortness of breath ▪ Anxiousness or panic ▪ Chest tightness or pain ▪ Coughing or wheezing attacks Source: https://www.mayoclinic.org/diseases-conditions/asthma/symptoms-causes/syc-20369653 | https://www.healthline.com/health/asthma#symptoms | https://www.aaaai.org/conditions-and- treatments/asthma ❖ The asthma have prevalence rate of 15-20 % in many countries. ❖ U.S have 7.6% of prevalence rate. ❖ Globally 339 million people are suffering from asthma. ❖ Anti-inflammatories and Anticholinergics are taken as medication for patient suffering from asthma. ❖ Teva Pharmaceutical Industries Ltd., Merck & Co., AstraZeneca Plc, GlaxoSmithKline Plc, Sanofi-Aventis SA, Philips Healthcare, Sunovion Pharmaceuticals, CareFusion Corporation, Inc., Boehringer Ingelheim GmbH and Roche are the leading players in asthma market.
  4. 4. Introduction 4 Asthma -Overview ❑ Treatment: ▪ Breathing exercises ▪ Quick-acting treatments ▪ Long-term asthma control medications ▪ Long-term asthma control medications • Anti-inflammatories • Anticholinergics • Long-acting bronchodilators • Biologic therapy drugs ❑ Medication are taken directly (oral) or by inhalation of corticosteroids (fluticasone (Flovent Diskus, Flovent HFA, Arnuity Ellipta), mometasone (Asmanex), budesonide (Pulmicort Flexhaler), ciclesonide (Alvesco), beclomethasone (Qvar), flunisolide (Aerobid) and others). Source: https://www.mayoclinic.org/diseases-conditions/asthma/symptoms-causes/syc-20369653 | https://www.healthline.com/health/asthma#symptoms | https://www.aaaai.org/conditions-and- treatments/asthma ❑ Diagnosis: ❑ No single test is design to test asthma. Doctor will ask about medical history of respiration infection and do physical examination. ▪ Test to determine the lung conditions: ▪ Spirometry ▪ Peak flow ❑ Doctor also ask to go for different test include: ▪ Allergy testing ▪ Sputum eosinophils ▪ Methacholine challenge ▪ Nitric oxide test or FeNO test ▪ Imaging tests
  5. 5. Asthma Prevalence Rate – U.S 5 Epidemiology -Asthma Source: https://www.who.int/news-room/fact-sheets/detail/asthma | https://www.aafa.org/asthma-facts/ | https://www.annalsofglobalhealth.org/articles/10.5334/aogh.2412/ ❑ Asthma is a noncommunicable diseases, more then 339 million people are effected with asthma globally. ❑ Globally 417,918 death occurs due to asthma and 24.6 million DALYS (Disability-adjusted life year) attributable to Asthma. ❑ 1 in 13 people suffer from asthma according to CDC (Centers for Disease Control and Prevention) in America. ❑ More than 25 million America suffer from asthma. In America the per person medical cost is approx. USD $ 3,266. ❑ The prevalence rate of asthma is range from 15-20% in many countries. U.S. Population - 2019 (Mn) 329.06 Mn Prevalence rate - 7.6% 25.01 Mn Global Asthma Epidemiology
  6. 6. THANK YOU

×